Market Research Blog

As per Future Market Insights (FMI), driven by rising cases of cancer and cardiovascular diseases, radiopharmaceutical market registered steady year-on-year growth at 4.90% CAGR in 2021.

Increasing development of radioisotopes to curb the cases of cancer have propelled the market demand, topping a valuation of US$ 6,107.2 Mn in 2021. Rising cases of prostate and breast cancer, especially in developed countries including the U.S., the U.K., and Germany, have increased the application of radiopharmaceuticals.

Government initiatives and research activities undertaken to develop advanced radioisotopes for the treatment of cancer and to develop novel therapeutics will boost the demand. Also, introduction of novel technologies such as Positron Emission Technology and others in nuclear imaging systems will bolster growth.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-1992

However, due to the global shutdown witnessed in the FQ-20 in response to the COVID-19 outbreak, growth declined considerably. Suspended production of radioisotopes and disruption in the research activities delayed the deployment of projects in the healthcare sector.

Although, with increasing development activities and increasing commercialization of radiopharmaceuticals by industry giants have picked up the pace for the growth of market. Alongside this, increasing cases of cancer will accelerate the development of nuclear medicines in the field of radiopharmaceuticals.

Increasing preference of non-invasive medical therapies and production of radioisotopes for the treatment is another factor that will stabilize the growth of radiopharmaceuticals market. Based on this, FMI projects the market is poised to expand at over 4.66% CAGR during the forecast period of 2021 and 2031.

Key Takeaways from FMI’s Radiopharmaceuticals Market Study

• In terms of application, oncology will contribute over 50% of global market share owing to the rising prevalence of cancer across the globe.
• Cyclotrons are expected to be the primary source of radiopharmaceuticals, accounting for maximum market share
• Based on radioisotope type, technetium-99 will remain highly preferred radioisotope in the global radiopharmaceutical market
• The U.S. will retain its global dominance backed by the high cancer and cardiovascular cases rising in the country
• India will emerge as lucrative market owing to the favorable government initiatives promoting the radiopharmaceuticals market
• Germany and the U.K. are spearheading the growth of Europe market, which is projected to grow at over 4.9% CAGR

Competitive Landscape

Leading radiopharmaceuticals market players are focusing on expanding their customer base through strategic mergers and acquisition. Increasing research and development activities to develop advanced radioisotopes for the cancer treatment is another core strategy adopted by leading players.

Top 5 players including Siemens AG, GE Healthcare, Curium, Lantheus Holdings Inc., and Eckert & Ziegler are dominating the global radiopharmaceuticals market, contributing over 90% of revenue share.

ESOMAR-certified consulting firm Future Market Insights (FMI) in its latest report forecasts that the global branded generics market will register healthy growth at a CAGR of 5.8% between 2021 and 2031.

The swift growth of branded generics market can be attributed to the growing number of patent expiry of branded or blockbuster drugs along with increasing prevalence of chronic diseases. Rising demand for cheap medical treatments is positively impacting the demand in the market.

Branded generics are pharmaceutical drugs that have been re-released with a different brand name. They are used to treat various diseases such as diabetes, hypertension, back pain and others. These drugs occupy small but lucrative subset of the entire generic market

Since branded generics are free from patenting, companies are investing handsome amounts on this drug category. The market is set to reach a valuation of around 283.2 Bn in 2021, with top players in tier-1 accounting for 20%-25% market share.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-1260

The entry of new players, simple market authorization procedures, greater profit margin and off-invoice discounts will expand branded generics market during the forecast period.

As per the FMI’s analysis, despite the slight setback due to the pandemic, the global branded generics market registered year-on-year (Y-o-Y) growth at 4.9% CAGR during 2020-2021.

Key Takeaways from FMI’s Branded Generics Market Study

• China and India are spearheading the growth of Asia Pacific market spurred by the increasing adoption of branded generics by large-scale pharmacy chains in the emerging economies
• The U.S. will lead the North America’s branded generics market, registering a growth at 3.83% CAGR during the forecast period.
• The market in India is expected to offer lucrative growth opportunities to branded generics manufacturers backed the expansion of pharmaceutical industry
• In terms of therapeutic application, cardiovascular diseases and diabetes are expected to account for considerable market share
• Oral solid dose pharmaceutical formulation continues to be highly preferred among patients. The oral segment accounts for over 55% share of the global branded generics market.

Competitive Landscape

Teva, Abbott Laboratories, Novartis, Mylan, Pfizer are some prominent players operating in the branded generics market cumulatively hold around 20-25% market share.

Key players operating in branded generic market are focusing on expanding their business in emerging markets. They are adopting various organic and inorganic growth strategies such as mergers and acquisitions, advanced product development and collaborations to gain a competitive edge in the market.

It has been reported that the brain slowly deteriorates as a person ages with the senses, memory and cognitive thinking abilities being affected the most. The deterioration of functions of the brain was explained by the loss of brain plasticity. Brain plasticity is the capacity of the nervous system to change its neural structure in reaction to environmental challenges. However research conducted in the last few years revealed that the brain retains the ability undergoe changes in size and shape in response to stimulation. Brain fitness is an umbrella term for techniques and strategies such as mental and cognitive training, neuroplasticity, neurogenesis, brain vascularization and others which are useful in keeping the brain fit. These are a set of mental exercises to sharpen the senses, memory and attention.

Brain Fitness Market: Drivers and Restraints

The burgeoning demand for brain fitness generated owing to increasing incidence of ADHD, learning disorders, memory loss, brain injury and others is driving a large market. According to the The A.D.D. Resource Center, Inc., 12.9 percent of men and 4.9 percent of women will be diagnosed with the attention disorder at some points in their lifetimes, with the prevalence of attention disorder being 4 percent of American adults over the age of 18. The American Psychiatric Association estimates that 5% of children have ADHD, while the Centers for Disease Control and Prevention (CDC) estimates that 11% of U.S. children aged 4 to 17 suffer from ADHD.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-8709

The growing ageing population is another driver of the market. The number of people aged 60 years or older is expected to rise from 900 million to 2 billion between 2015 and 2050, representing a growth from 12% to 22% of the total global population, according to recent World Health Organization report. The prosperous baby boomer population of U.S. is another driver for the market owing to their desire to delay dementia and mental disorders. Thus a large market is well evident.

However the constraints such as lack of awareness, lack of experimental validation regarding the effectiveness and efficacy of the brain fitness therapy and opposition to clinical acceptance is hampering the brain fitness market. Actions by regulatory bodies such as the United States Federal Trade Commission (FTC) which sued companies selling “brain training” programs such as WordSmart Corporation and LearningRx, for deceptive advertising in 2015 is the greatest threat to the market.

Brain Fitness Market: Regional Wise Outlook

The global brain fitness market can be classified into the following region: North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, and Middle East and Africa. North America, led by the U.S., is expected to drive the largest market share owing to the large incidence of neurological disorders,, ageing baby boomer population and large per capita income.

The Asia Pacific brain fitness market excluding Japan is anticipated to grow owing to the growing awareness and rising incomes. China and India are projected to lead the Asia Pacific brain fitness market growth. Germany, France and the U.K., are projected to be the largest drivers of the Europe brain fitness market. The Middle East and Africa brain fitness market is expected to be led by the gulf economies of Saudi Arabia, Kuwait, UAE and Qatar owing to their large wealth.

Brain Fitness Market: Market Participants

Some of the major vendors operating in the global brain fitness market are AttenGo Ltd., Nintendo, CogniFit , NEEURO, PTE LTD, Synaptikon GmbH, BrainTrain, SMARTfit Inc., Applied Cognitive Engineering,BrainHQ, Lumos Labs, Inc., Total Brain Health, Advanced Brain Technologies, Cogstate, Cogmed, CNS Vital Signs, Lexia Learning, MyBrainTrainer, NovaVision, and others.

The global brain fitness report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

DNA-based skin care is the development and formulation of personalized skincare specific to the DNA of the patient. It includes extracting the DNA by a cheek swab and analyzing it to identify the skin’s inherit condition across several factors such as collagen formation, inflammation, glycation, antioxidant and sun protection and others. The last step is development ad formulation of customized skin care products targeting the needs of the skin for the user.

DNA-Based Skin Care Market: Drivers and Restraints

The advancements in genomics coupled with the development of infrastructure and awareness is the prime driver of the market. The growing expenditure on wellness products and the inherent desire to be young are another driver of the market. It has been estimated that the global wellness economy, and wellness tourism is estimated to total US$ 500 billion in 2016.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-8702

The growing influence of media and the tourism industry are psychographic drivers of the market. Further the falling cost of genetic diagnostics have resulted in high potential of skin care tailored to one’s DNA and lifestyle. Intrinsic skin ageing accounts for 60% of skin damage, while the remaining 40% is due to external factors and lifestyle. Thus a large DNA-based skin care market is well evident even to an untrained eye.

A strong developmental pipeline is another driver of the market. Companies are investing in personalized medicines which is expected to be the future of healthcare.

However the constraints such as high cost of treatment, nascent stage of technology and low awareness in under developed nations is hampering the DNA-based skin care market.

DNA-Based Skin Care Market: Regional Wise Outlook

The global DNA-based skin care market can be classified into the following region: North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America, led by the U.S., is expected to drive the largest market share owing to the large wellness expenditure, large per capita income and large international wellness tourism. The US is the top destination for international wellness tourism, averaging 7.0 million international travels in 2016.

The Asia Pacific DNA-based skin care market excluding Japan is projected to expand and dominate the scene in the near future, owing to the growing healthcare expenditure and income. China and India are anticipated to account for the major share of the Asia Pacific DNA-based skin care market growth. The Asia-Pacific region is expected to grow at a faster pace owing to traditional dominance of alternative therapies such as Ayurveda, traditional Chinese medicine, Thai massage) which incorporate preventive, curative, and therapeutic aspects closing near the wellness treatment.

Germany, France and the U.K., are projected to be the largest drivers of the Europe DNA-based skin care market. The Middle East and Africa DNA-Based Skin Care market is anticipated to be led by the gulf countries of Saudi Arabia, UAE and Qatar owing to their large income.

DNA-Based Skin Care Market: Market Participants

Some of the major vendors operating in the global DNA-based skin care market are Imagene Labs, Caligenix, EpigenCare, SkinGenie, ALLÉL, dnaskin, SkinDNA, Jinomz, Targeted DNA, Evergreen Health Solutions Ltd., EpigenCare Inc. and others.

The global DNA-Based Skin Care report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

A bovine pericardial valve is an artificial bio-prosthetic cardiac valve with a three-cusp structure made from chemically treated bovine pericardium on a suitable framework such as a titanium frame. A bovine pericardial valve is used to replace a diseased or faulty natural heart valve which allows unidirectional flow of blood.

Bovine Pericardial Valve Market: Drivers and Restraints

The growing demand generated due to the increasing incidence of cardiac and valve diseases owing to the increasing incidence of cardiopathies such as sinus node dysfunction and heart block are the prime drivers of the bovine pericardial valve market. Heart valve disease affects approximately 5 million Americans every year. Risk factors such as infections of the valves, rheumatic fever, heart attack, advanced heart failure or atherosclerosis, high cholesterol, high blood pressure, being overweight, autoimmune disorders including lupus, rheumatoid arthritis and others are driving a large market.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-8654

According to the center for disease control and prevention, about 610,000 U.S. citizens die of heart disease each year. Coronary heart disease (CHD) is the major heart disease, resulting in over 370,000 deaths each year. The statistics also point to the fact that about 735,000 Americans suffer from a heart attack per year. Speaking in economic terms, heart disease costs about $200 billion each year to the U.S. exchequer, which includes the cost of health care services, medications, and lost productivity. Thus a large bovine pericardial valve market is well evident even to an untrained eye.

The demographic drivers of the bovine pericardial valve market are growing the older population, sedentary lifestyles leading to obesity, substance abuse, junk food and others. The growing incidence of diseases such as diabetes, hypertension and other autoimmune diseases are other drivers of the market. According to the center for disease control and prevention, almost 70 million Americans representing some 30% of the population suffer from hypertension.

Technological advancements resulting in product development such as the development of customized bovine pericardial valve is driving a faster bovine pericardial valve market adoption. Development of inert materials such as silicon is expected to result in growing functionality and market adoption owing to superior performance.

However, the high cost of the bovine pericardial valve, competition from drug therapy, scarcity of experienced surgeons, the lower per capita income of the developing world and the high risk of surgery is hampering the bovine pericardial valve market.

Bovine Pericardial Valve Market: Regional Wise Outlook

The global Bovine pericardial valve market can be classified into the following region: North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East, and Africa. North America, led by the U.S., is expected to account for the largest share in the global bovine pericardial valve market, owing to the large demand, large healthcare expenditure, and large per capita income in the region.

The Asia Pacific bovine pericardial valve market excluding Japan is projected to expand and dominate the scene in the near future, owing to the growing healthcare and large specialty hospitals.

China and India are anticipated to account for the major share of the Asia Pacific bovine pericardial valve market growth. Germany, France, and the U.K., are projected to be the largest drivers of the Europe Bovine pericardial valve market. The Middle East and Africa Bovine pericardial valve market is anticipated to be dominated by the Gulf economies of Saudi Arabia, Kuwait, UAE and Qatar.

Bovine Pericardial Valve Market: Market Participants

Some of the major vendors operating in the global Bovine pericardial valve market are Edwards Lifesciences, Medtronic, Meril Life Sciences Pvt. Ltd., Boston Scientific Corporation, Labor Laboratórios Ltda., Abbott, Colibri Heart Valve, St. Jude Medical, and others.

The global bovine pericardial valve report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.